-       Clinical Trials 
   - April 2025
    -  40 Pages 
    Global
   
   From       €899EUR$1,000USD£788GBP 
      €1124EUR$1,250USD£985GBP 
                -       Report 
   - May 2025
    -  118 Pages 
    Global
   
   From       €4269EUR$4,750USD£3,744GBP 
                -       Report 
   - July 2025
     Global
   
   From       €4404EUR$4,900USD£3,862GBP 
                From       €4404EUR$4,900USD£3,862GBP 
                -       Report 
   - January 2025
    -  175 Pages 
    Global
   
   From       €4036EUR$4,490USD£3,539GBP 
                   -       Report 
   - June 2025
    -  150 Pages 
    Global
   
   From       €2291EUR$2,549USD£2,009GBP 
      €2696EUR$2,999USD£2,364GBP 
                  -       Report 
   - August 2025
    -  182 Pages 
    Global
   
   From       €3186EUR$3,545USD£2,794GBP 
      €3540EUR$3,939USD£3,105GBP 
                -       Report 
   - June 2025
    -  182 Pages 
    Global
   
   From       €4045EUR$4,500USD£3,547GBP 
                -       Report 
   - February 2025
    -  190 Pages 
    Global
   
   From       €4045EUR$4,500USD£3,547GBP 
                -       Report 
   - February 2025
    -  183 Pages 
    Global
   
   From       €4045EUR$4,500USD£3,547GBP 
                -       Report 
   - November 2024
    -  156 Pages 
    Global
   
   From       €2247EUR$2,500USD£1,971GBP 
                  -       Report 
   - October 2025
    -  150 Pages 
    Global
   
   From       €3460EUR$3,850USD£3,035GBP 
                -       Report 
   - September 2025
    -  150 Pages 
    Global
   
   From       €3460EUR$3,850USD£3,035GBP 
                -       Report 
   - August 2025
    -  150 Pages 
    Global
   
   From       €3460EUR$3,850USD£3,035GBP 
                  -       Report 
   - April 2025
    -  150 Pages 
    Global
   
   From       €3460EUR$3,850USD£3,035GBP 
      €4359EUR$4,850USD£3,823GBP 
                  -       Report 
   - December 2024
    -  150 Pages 
    Global
   
   From       €3460EUR$3,850USD£3,035GBP 
      €4359EUR$4,850USD£3,823GBP 
                  -       Report 
   - November 2024
    -  150 Pages 
    Global
   
   From       €3460EUR$3,850USD£3,035GBP 
      €4359EUR$4,850USD£3,823GBP 
                -       Report 
   - June 2025
    -  150 Pages 
    Global
   
   From       €2426EUR$2,699USD£2,128GBP 
                -       Report 
   - June 2025
    -  200 Pages 
    Global
   
   From       €2507EUR$2,789USD£2,198GBP 
                -       Drug Pipelines 
   - June 2025
    -  200 Pages 
    Global
   
   From       €2507EUR$2,789USD£2,198GBP 
             
         The Dermatologicals market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin diseases, including acne, psoriasis, eczema, and skin cancer. Dermatologicals are typically administered topically, although some may be taken orally. The market is highly competitive, with a wide range of products available from both generic and branded manufacturers.
The Dermatologicals market    is driven by the increasing prevalence of skin diseases, as well as the development of new treatments and technologies. Additionally, the increasing demand for cosmetic treatments has also contributed to the growth of the market.
Some of the major companies in the Dermatologicals market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. Other notable players include Allergan, Galderma, and Sun Pharmaceuticals. Show Less   Read more